Bio-Reactor or Bio-Rocket? Scaling Up with Arsenale Bio's Massimo Portincaso
Karl and Erum sit down with Massimo Portincaso, founder of Arsenale BioYards, to discuss the urgent need to rethink how we scale biomanufacturing. Massimo shares why today’s approach to industrial biotech—modeled after biopharma—is fundamentally flawed and how Arsenale is flipping the script. From nature co-design to AI-driven strain selection, he lays out a bold vision for scaling bio-based production in a way that is economically viable and industrially scalable. If you care about the future of precision fermentation, sustainable materials, and the bioeconomy, this is a conversation you don’t want to miss!
